Literature DB >> 31108576

The Role of Inclusion Benefits in Ethics Committee Assessment of Research Studies.

Stuart Rennie1, Suzanne Day2, Allison Mathews3, Adam Gilbertson4, Winfred K Luseno5, Joseph D Tucker6, Gail E Henderson7.   

Abstract

The relationship between risks and benefits is central to the ethics of research involving human participants. Traditionally, to be ethically justifiable, risks should be reasonable in relation to anticipated benefits (if any) to subjects and to the potential social benefits resulting from research. This calculus is being further complicated by findings from an increasing number of social science studies that reveal that prospective and actual research participants frequently describe various types of inclusion benefits (for example, personal benefits such as access to or improved health care, increased knowledge about their disease or condition, and greater solidarity with the local community) as important to them. What is the ethical significance of such inclusion benefits, particularly those nonmedical in nature, for research ethics committees' risk-benefit assessment of research studies? We argue that, unless participants are clearly mistaken in their perceptions, ethics committees should take these types of inclusion benefits into account, and we suggest a few ways this might look in practice.
© 2019 by The Hastings Center. All rights reserved.

Entities:  

Keywords:  human research ethics; inclusion benefits; institutional review boards; research ethics committees; risk-benefit assessment

Mesh:

Year:  2019        PMID: 31108576      PMCID: PMC8162785          DOI: 10.1002/eahr.500015

Source DB:  PubMed          Journal:  Ethics Hum Res        ISSN: 2578-2355


  25 in total

1.  Thinking clearly about research risk: implications of the work of Benjamin Freedman.

Authors:  C Weijer
Journal:  IRB       Date:  1999 Nov-Dec

Review 2.  The ethical analysis of risk.

Authors:  C Weijer
Journal:  J Law Med Ethics       Date:  2000       Impact factor: 1.718

Review 3.  Defining and describing benefit appropriately in clinical trials.

Authors:  N M King
Journal:  J Law Med Ethics       Date:  2000       Impact factor: 1.718

Review 4.  Ending concerns about undue inducement.

Authors:  Ezekiel J Emanuel
Journal:  J Law Med Ethics       Date:  2004       Impact factor: 1.718

5.  Medical researchers' ancillary clinical care responsibilities.

Authors:  Leah Belsky; Henry S Richardson
Journal:  BMJ       Date:  2004-06-19

6.  The right to participate in high-risk research.

Authors:  David Shaw
Journal:  Lancet       Date:  2013-09-18       Impact factor: 79.321

7.  Indirect Benefits in HIV Cure Clinical Research: A Qualitative Analysis.

Authors:  Adam Gilbertson; Elizabeth Poole Kelly; Stuart Rennie; Gail Henderson; JoAnn Kuruc; Joseph D Tucker
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-22       Impact factor: 2.205

8.  Positive Social Impacts Related to Participation in an HIV Prevention Trial Involving People Who Inject Drugs.

Authors:  Jeremy Sugarman; Randy Stalter; Kevin Bokoch; Ting-Yuan Liu; Deborah Donnell
Journal:  IRB       Date:  2015 Jan-Feb

9.  Benefits and payments for research participants: experiences and views from a research centre on the Kenyan coast.

Authors:  Sassy Molyneux; Stephen Mulupi; Lairumbi Mbaabu; Vicki Marsh
Journal:  BMC Med Ethics       Date:  2012-06-22       Impact factor: 2.652

10.  Benefits and burdens of participation in a longitudinal clinical trial.

Authors:  Jaime Lazovski; Marcelo Losso; Benjamin Krohmal; Ezekiel J Emanuel; Christine Grady; David Wendler
Journal:  J Empir Res Hum Res Ethics       Date:  2009-09       Impact factor: 1.742

View more
  8 in total

1.  Participant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group 5366.

Authors:  Karine Dubé; Lara Hosey; Kate Starr; Liz Barr; David Evans; Erin Hoffman; Danielle M Campbell; Jane Simoni; Jeremy Sugarman; John Sauceda; Brandon Brown; Karen L Diepstra; Catherine Godfrey; Daniel R Kuritzkes; David A Wohl; Rajesh Gandhi; Eileen Scully
Journal:  AIDS Res Hum Retroviruses       Date:  2020-04       Impact factor: 2.205

2.  Awareness of Jordanian Investigators About the Importance of Ethics Review Committees: A Pilot Study.

Authors:  Abeer M Rababa'h; Karem H Alzoubi; Mera Ababneh; Omar F Khabour
Journal:  Sci Eng Ethics       Date:  2019-09-30       Impact factor: 3.525

3.  Perceptions of Next-of-Kin/Loved Ones About Last Gift Rapid Research Autopsy Study Enrolling People with HIV/AIDS at the End of Life: A Qualitative Interview Study.

Authors:  Karine Dubé; Hursch Patel; Susan Concha-Garcia; Kelly E Perry; Kushagra Mathur; Sogol Stephanie Javadi; Jeff Taylor; Andy Kaytes; Brandon Brown; John A Sauceda; Susan Little; Steven Hendrickx; Stephen A Rawlings; Davey M Smith; Sara Gianella
Journal:  AIDS Res Hum Retroviruses       Date:  2020-06-25       Impact factor: 2.205

4.  Participant Perspectives and Experiences Entering an Intensively Monitored Antiretroviral Pause: Results from the AIDS Clinical Trials Group A5345 Biomarker Study.

Authors:  Karen L Diepstra; Liz Barr; David Palm; Evelyn Hogg; Katie R Mollan; Laney Henley; Angela M Stover; Jane M Simoni; Jeremy Sugarman; Brandon Brown; John A Sauceda; Steven Deeks; Lawrence Fox; Rajesh T Gandhi; Davey Smith; Jonathan Z Li; Karine Dubé
Journal:  AIDS Res Hum Retroviruses       Date:  2021-02-16       Impact factor: 1.723

5.  Participant Perspectives and Experiences Following an Intensively Monitored Antiretroviral Pause in the United States: Results from the AIDS Clinical Trials Group A5345 Biomarker Study.

Authors:  Karine Dubé; Shadi Eskaf; Liz Barr; David Palm; Evelyn Hogg; Jane M Simoni; Jeremy Sugarman; Brandon Brown; John A Sauceda; Laney Henley; Steven Deeks; Lawrence Fox; Rajesh T Gandhi; Davey Smith; Jonathan Z Li
Journal:  AIDS Res Hum Retroviruses       Date:  2022-04-21       Impact factor: 1.723

Review 6.  Altruism: Scoping review of the literature and future directions for HIV cure-related research.

Authors:  Karine Dubé; Kelly E Perry; Kushagra Mathur; Megan Lo; Sogol S Javadi; Hursch Patel; Susanna Concha-Garcia; Jeff Taylor; Andy Kaytes; Lynda Dee; Danielle Campbell; John Kanazawa; David Smith; Sara Gianella; Judith D Auerbach; Parya Saberi; John A Sauceda
Journal:  J Virus Erad       Date:  2020-08-25

Review 7.  Ethics of HIV cure research: an unfinished agenda.

Authors:  Karine Dubé; John Kanazawa; Jeff Taylor; Lynda Dee; Nora Jones; Christopher Roebuck; Laurie Sylla; Michael Louella; Jan Kosmyna; David Kelly; Orbit Clanton; David Palm; Danielle M Campbell; Morénike Giwa Onaiwu; Hursch Patel; Samuel Ndukwe; Laney Henley; Mallory O Johnson; Parya Saberi; Brandon Brown; John A Sauceda; Jeremy Sugarman
Journal:  BMC Med Ethics       Date:  2021-06-30       Impact factor: 2.834

Review 8.  Applying the Behavioural and Social Sciences Research (BSSR) Functional Framework to HIV Cure Research.

Authors:  Karine Dubé; Judith D Auerbach; Michael J Stirratt; Paul Gaist
Journal:  J Int AIDS Soc       Date:  2019-10       Impact factor: 5.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.